Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1182 (LINC01182)

Target
LINC01182
Molecular classification
Long intergenic non-coding RNA, lincRNA, lncRNA
01

Overview

Long intergenic non-protein coding RNA 1182 (LINC01182) is a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs (lncRNAs) found in the human genome[1][3]. LINC01182 does not encode a protein but is instead transcribed as an RNA molecule longer than 200 nucleotides. lincRNAs, including LINC01182, typically regulate gene expression, frequently through interactions with DNA, RNA, or protein complexes involved in chromatin modification, transcriptional, or post-transcriptional control[4][7]. Co-expression network analyses suggest that LINC01182 is connected with biological processes such as cell adhesion, cell migration, and cell–extracellular matrix interactions, which are relevant to cancer cell behavior[2]. While lncRNAs, including many lincRNAs, are implicated in cancer and other diseases, there is currently limited evidence for direct drug targeting or biomarker usage specific to LINC01182.\n\n**LINC01182 is not a classical therapeutic target** (e.g., receptor, enzyme, transporter), but is of increasing research interest as a potential regulator in disease pathways through modulation of gene expression networks[7].

Other names
LINC01182LINC01085
02

Biological functions

Regulation of gene expressionCell adhesionCell migrationCell–extracellular matrix interaction
03

Disease associations

Cancer (potential, based on lncRNA dysregulation in cancers; specific disease involvement for LINC01182 is not strongly documented)Other (emerging evidence for lncRNAs, including LINC01182, in diverse diseases, but LINC01182-specific evidence is limited)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1182 (LINC01182).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1182 (LINC01182).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call